Crystalline forms of a pyridine derivative
US8093242B2 · kind B2 · utility
4Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2009 |
| Grant date | Jan 10, 2012 |
| Priority date | — |
| Expiry date | Aug 4, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 4-methylbenzenesulfonate salt of the compound of formula (I)in a crystalline form or a solvate thereof, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.